I came across this nifty diagram showing how being inactive contributes to illness. Get moving to stay healthy! When you don't move you gain weight, especially around the middle. White blood cells from your immune system move into the fat around your organs. This ignites inflammation everywhere in your body, which leads to insulin resistance and more weight gain, and ultimately diabetes. This raises your risk for heart disease, high blood pressure and stroke. This inflammation also leads to brain issues like dementia, Parkinsons and Alzheimers. Also increased is your risk for cancer. It is worth saying again. Get moving to protect your health!
Welcome
Who says we have to suffer...to live a healthy happy vibrant life?
Red wine and dark chocolate... might seem decadent...but these guilty pleasures also might help us live longer...and healthier lives. Red wine and dark chocolate definitely improve an evening..but they also contain resveratrol..which lowers blood sugar. Red wine is a great source of catechins..which boost protective HDL cholesterol. Green tea? Protects your brain..helps you live longer..and soothes your spirit.
Food for Thought, the blog, is about living the good life...a life we create with our thoughts and our choices...and having fun the whole while!
I say lets make the thoughts good ones..and let the choices be healthy...exciting...and delicious! Bon Appetit!
Showing posts with label Cancer. Show all posts
Showing posts with label Cancer. Show all posts
Monday, November 12, 2018
Monday, December 12, 2016
High Fat Diet Fuels Cancer's Spread in Mice.

It is a difficult and hazardous
undertaking for a cancer cell to uproot itself, travel through the bloodstream
and take hold in an entirely different part of the body. (Non-cancerous cells
are often programmed to self-destruct if they leave the tissue they live in.)
Researchers have long struggled to understand which cancer cells can manage the
feat, and how they do so.
But a study published on 7 December
in Nature has identified a population of oral tumor cells that are
able to make the journey in mice, and has found that such cells may feast on
fats to fuel the trip. Determining how certain cancer cells spread throughout
the body — a process called metastasis — is a big step forward, says Xiang
Zhang, a cancer researcher at Baylor College of Medicine in Houston, Texas, who
was not involved in the study. “Now people have a suspect they can follow.”
To find that suspect, Salvador
Aznar Benitah of the Institute for Research in Biomedicine at the Barcelona
Institute of Science and Technology in Spain and his colleagues looked among
oral-cancer cells for those that could seed tumors. Within that population of
cells, the team found some that expressed high levels of a molecule called
CD36, which helps cells to take up lipids from their environment.
Stopping the spread
Benitah and his team found that
high CD36 expression was required for metastasis in mice. Antibodies that
blocked CD36 — and eliminated its interaction with fatty acids — completely
inhibited metastasis, although they did not affect the development of primary
tumors.
The researchers also mined public
databases and found that high expression of CD36 correlated with poor medical
outcomes in bladder, lung, breast and other cancers in people.
Benitah’s team is now working to
develop antibodies against CD36 that could be used in clinical trials, although
he estimates it would take at least another four years to reach that milestone.
Benitah notes that such a therapy may be effective even after cancer has
started to spread: in mice, experimental antibodies eradicated metastatic
tumors 15% of the time. The remaining metastatic tumors shrunk by at least 80%.
The team is also looking at the
implications of another finding: feeding the mice a high-fat diet led to more
and larger tumors in the lymph nodes and lungs — a sign of metastasis —
compared with mice on normal diets.
They went on to test a specific
saturated fatty acid called palmitic acid -- a major component of animal and
vegetable fats and present at high levels in palm oil which is used in many
house hold products from peanut butter and processed food to toothpaste. The
researchers treated human oral tumours with palmitic acid for two days then
injected them into mice fed a standard diet. The team observed that all the
mice with CD36 developed cancer spread compared to only half when not treated
with palmitic acid.
Benitah’s team is now carrying out
a study that aims to enroll 1,000 people with cancer, profiling lipids in their
blood to look for any links to the spread of cancer cells.
Journal Reference:
Gloria Pascual, Alexandra
Avgustinova, Stefania Mejetta, Mercè Martín, Andrés Castellanos, Camille
Stephan-Otto Attolini, Antoni Berenguer, Neus Prats, Agustí Toll, Juan Antonio
Hueto, Coro Bescós, Luciano Di Croce, Salvador Aznar Benitah. Targeting
metastasis-initiating cells through the fatty acid receptor CD36. Nature,
2016
Friday, July 22, 2016
What if everything you believe about mammograms has been wrong?
Ladies? Mammograms are the best way you can
stay safe from breast cancer right?
Last year, results from a 25-year follow-up of
two landmark studies tracking about 90,000 women concluded that mammography did
not reduce breast cancer deaths at all.
In fact a mammogram means you are at
least three times more likely to be diagnosed and treated for a cancer that
never would have harmed you rather than saving your life. But perhaps the most
infuriating thing is that scientific evidence for the harms of mammography has
been available—published in medicine's most highly regarded journals—for
decades.
Before you rush to that annual screening
please read this very informative article on the reality of mammograms and the very
real possibility of false positives and overdiagnosis.
Wednesday, April 13, 2016
Here comes the sun, or rather the sunshine vitamin, to the rescue against cancer.
Lower levels of vitamin D have been linked with a higher risk of cancer,
researchers have found. The study supports a link found between vitamin D status and rates of breast, lung and bladder cancer first seen in the 1980s.
My hope is that the findings from this research might shape healthcare guidelines by identifying vitamin D status as a key prevention tool. Being aware of the relationship of cancer and low vitamin D would allow primary prevention to slow or reverse upward trends in cancer incidence, treatment burden, mortality, and associated costs.
Look at 2012. There were 14 million new cases of cancer worldwide in 2012 and 8.2 million cancer- related deaths. The annual number of new cases is projected to increase to 22 million within the next twenty years.
In Europe and North America cancer is the most significant cause of death and morbidity after cardiovascular diseases.
In this study, University of California, San Diego School of Medicine researchers sought to determine what blood level of vitamin D was required to effectively reduce cancer risk. They were specifically looking at 25-hydroxyvitamin D, the main form of vitamin D in the blood, as a marker for vitamin D levels. They combined data from two previous studies. One was a randomized clinical trial of 1,169 women (Lappe trial cohort) and the other was a prospective cohort study of 1,135 women (GrassrootsHealth cohort). By combining the two studies, the researchers were able to work from a larger sample size and a greater range of blood serum levels of 25-hydroxyvitamin D (25(OH)D).
It is generally accepted that the most accurate measure of vitamin D levels in a person is a blood test. In the Lappe trial cohort, the median blood serum level of 25(OH)D was 30 nanograms (ng) per millilitre (ml). In the GrassrootsHealth prospective cohort, it was higher: 48 ng/ml. The team found that the age-adjusted cancer incidence was 1,020 cases per 100,000 person-years in the Lappe cohort and 722 per 100,000 person-years in the GrassrootsHealth cohort.
In other words, rates of cancer declined with increased 25(OH)D levels. Females with 25(OH)D concentrations of 40 ng/ml or greater had a 67% lower risk of cancer than women with levels of 20 ng/ml or less.
"These findings support an inverse association between 25(OH)D and risk of cancer," said Dr Cedric Garland, adjunct professor in the UC San Diego School of Medicine Department of Family Medicine and Public Health and member of Moores Cancer Center at UC San Diego Health.
“It highlights the importance for cancer prevention of achieving a vitamin D blood serum
A population based study found a 63% lower risk of breast cancer for women with 25(OH)D concentrations of 30 ng/ml compared to women with concentrations of less than 20 ng/ml, with a 71% lower risk among post-menopausal women.
A nested case control study found a 55% lower risk of colorectal cancer in women with 25(OH)D concentrations of 29 ng/ml compared to women with concentrations of less than 18 ng/ml.
The wealth of studies has made recommending an optimum blood serum level of vitamin D difficult to establish.
Garland did not identify a singular, optimum daily intake of vitamin D or the manner of intake, which may be sunlight exposure, diet and/or supplementation.
He stated that the current study clarified that reduced cancer risk became measurable at 40 ng/ml, with additional benefit at higher levels.
All of this means that a target vitamin D level recommended by the US Institute of Medicine of 20g/mL is not ideal for reducing cancer risk. If that is the goal higher blood levels may be advised.
My hope is that the findings from this research might shape healthcare guidelines by identifying vitamin D status as a key prevention tool. Being aware of the relationship of cancer and low vitamin D would allow primary prevention to slow or reverse upward trends in cancer incidence, treatment burden, mortality, and associated costs.
Look at 2012. There were 14 million new cases of cancer worldwide in 2012 and 8.2 million cancer- related deaths. The annual number of new cases is projected to increase to 22 million within the next twenty years.
In Europe and North America cancer is the most significant cause of death and morbidity after cardiovascular diseases.
In this study, University of California, San Diego School of Medicine researchers sought to determine what blood level of vitamin D was required to effectively reduce cancer risk. They were specifically looking at 25-hydroxyvitamin D, the main form of vitamin D in the blood, as a marker for vitamin D levels. They combined data from two previous studies. One was a randomized clinical trial of 1,169 women (Lappe trial cohort) and the other was a prospective cohort study of 1,135 women (GrassrootsHealth cohort). By combining the two studies, the researchers were able to work from a larger sample size and a greater range of blood serum levels of 25-hydroxyvitamin D (25(OH)D).
It is generally accepted that the most accurate measure of vitamin D levels in a person is a blood test. In the Lappe trial cohort, the median blood serum level of 25(OH)D was 30 nanograms (ng) per millilitre (ml). In the GrassrootsHealth prospective cohort, it was higher: 48 ng/ml. The team found that the age-adjusted cancer incidence was 1,020 cases per 100,000 person-years in the Lappe cohort and 722 per 100,000 person-years in the GrassrootsHealth cohort.
In other words, rates of cancer declined with increased 25(OH)D levels. Females with 25(OH)D concentrations of 40 ng/ml or greater had a 67% lower risk of cancer than women with levels of 20 ng/ml or less.
"These findings support an inverse association between 25(OH)D and risk of cancer," said Dr Cedric Garland, adjunct professor in the UC San Diego School of Medicine Department of Family Medicine and Public Health and member of Moores Cancer Center at UC San Diego Health.
“It highlights the importance for cancer prevention of achieving a vitamin D blood serum
concentration above 20 ng/ml, the concentration recommended by the Institute of
Medicine for bone health."
The results suggest the importance of vitamin D for the prevention of cancer and are supported by a number of additional studies that have also found a similar reduction in risk for individual cancers.
In a hospital-based case control study women with serum concentrations of more than 60 ng/ml had an 83% reduction in breast cancer risk compared to women with concentrations less than 20 ng/ml.
The results suggest the importance of vitamin D for the prevention of cancer and are supported by a number of additional studies that have also found a similar reduction in risk for individual cancers.
In a hospital-based case control study women with serum concentrations of more than 60 ng/ml had an 83% reduction in breast cancer risk compared to women with concentrations less than 20 ng/ml.
A population based study found a 63% lower risk of breast cancer for women with 25(OH)D concentrations of 30 ng/ml compared to women with concentrations of less than 20 ng/ml, with a 71% lower risk among post-menopausal women.
A nested case control study found a 55% lower risk of colorectal cancer in women with 25(OH)D concentrations of 29 ng/ml compared to women with concentrations of less than 18 ng/ml.
The wealth of studies has made recommending an optimum blood serum level of vitamin D difficult to establish.
Garland did not identify a singular, optimum daily intake of vitamin D or the manner of intake, which may be sunlight exposure, diet and/or supplementation.
He stated that the current study clarified that reduced cancer risk became measurable at 40 ng/ml, with additional benefit at higher levels.
All of this means that a target vitamin D level recommended by the US Institute of Medicine of 20g/mL is not ideal for reducing cancer risk. If that is the goal higher blood levels may be advised.
“Serum 25-Hydroxyvitamin D Concentrations 40 ng/ml Are Associated with >65% Lower
Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.”
Authors: Sharon McDonnell, Carole Baggerly, Christine French, Leo Baggerly, Cedric Garland, Edward Gorham, Joan Lappe, Robert Heaney.
Authors: Sharon McDonnell, Carole Baggerly, Christine French, Leo Baggerly, Cedric Garland, Edward Gorham, Joan Lappe, Robert Heaney.
Saturday, May 16, 2015
10 Health Benefits of Broccoli and a Bonus!

2. Curbs overeating. A cup of broccoli has as much protein as a cup of rice or corn but only half the calories. Plus broccoli is a great source of fiber.
3. Boosts your immune function. A cup of broccoli has a powerful supply of beta-carotene, zinc and selenium which strengthen your ability to fight infections.
4. Fights birth defects. A cup of broccoli provides 94mcg of folate, a B vitamin important for proper fetal development.
5. Fights Diabetes. The high fiber, low sugar and low calories keep insulin function tuned up and support stable blood sugar levels.
6. Fights Heart Disease. The carotenoid lutein, vitamin B-6 and folate in broccoli may reduce the risk of atherosclerosis, heart disease and stroke.
7. Promotes strong and healthy bones. Broccoli provides calcium and vitamin K which promote bone health and reduce risk of osteoporosis.
8. Regulates blood pressure. The potassium, magnesium and calcium work together to support blood pressure in the normal range.
9. Reduces incidence and severity of colds. Vitamin C and Vitamin A, antioxidants and anti-infectives help support resistance to respiratory infections.
10. Makes for healthy women and manly men. Broccoli provides diindolylmethane which supports healthy estrogen balance and reduces accumulation of harmful estrogens in women all the while supporting healthy testosterone levels in men.

Broccoli Rabe a Mediterranean favorite confers the same benefits!
Thursday, June 5, 2014
The Cancer Fighting/Promoting Power of Foods.
No single food can reduce your risk of
cancer, but the right combination of foods may help make a difference. At
mealtimes, strike a balance of at least 2/3 plant-based foods and no more than
1/3 animal protein. This "New American Plate" is an important cancer
fighting tool, according to the American Institute for Cancer Research. Check
out better and worse choices for your plate.
Fighting
Cancer With Color
Fruits
and vegetables are rich in cancer-fighting nutrients - and the more color, the
more nutrients they contain. These foods can help lower your risk in a second
way, too, when they help you reach and maintain a healthy body weight. Carrying
extra pounds increases the risk for multiple cancers, including colon,
esophagus, and kidney cancers. Aim for five to nine servings a day, prepared
in a healthy way.
The
Cancer-Fighting Breakfast
Folate is
an important B vitamin that may help protect against cancers of the colon,
rectum, and breast. You can find it in abundance on the breakfast table.
Fortified breakfast cereals and whole wheat products are good sources of folate. So
are orange juice, melons, and strawberries.
Folate the rest of the day.
Other
good sources of folate are
asparagus and eggs. You can also find it in chicken liver, beans, sunflower
seeds, and leafy green vegetables like spinach or romaine lettuce. According to
the ACS, the best way to get folate is not from a pill, but by eating enough
fruits, vegetables, and enriched grain products.
Cancer
Fighting Tomatoes.
Whether
it's the lycopene --
the pigment that gives tomatoes their red color -- or something else isn't
clear. But some studies have linked eating tomatoes to reduced risk of several
types of cancer, including prostate cancer. Studies also suggest that processed
tomato products such as juice, sauce, or paste increase the cancer-fighting
potential.
Tea especially green tea, may be a strong
cancer fighter. In laboratory studies, green tea has slowed or prevented the
development of cancer in colon, liver, breast, and prostate cells. It also had
a similar effect in lung tissue and skin. And in some longer term studies, tea
was associated with lower risks for bladder, stomach, and pancreatic cancers.
Grapes
and grape juice, especially purple and red grapes, contain resveratrol. Resveratrol has
strong antioxidant and anti-inflammatory properties. In laboratory studies, it
has prevented the kind of damage that can trigger the cancer process in cells.
There is not enough evidence to say that eating grapes or drinking grape juice
or wine can prevent or treat cancer.
Water
not only quenches your thirst, but it may protect you against bladder cancer.
The lower risk comes from water diluting concentrations of potential
cancer-causing agents in the bladder. Also, drinking more fluids causes you to
urinate more frequently. That lessens the amount of time those agents stay in
contact with the bladder lining.
Beans
are so good for you, it's no surprise they may help fight cancer, too.
They contain several potent phytochemicals that
may protect the body's cells against damage that can lead to cancer. In the lab
these substances slowed tumor growth and prevented tumors from releasing
substances that damage nearby cells.
Cruciferous
vegetables include broccoli, cauliflower, cabbage, Brussels sprouts, bok choy, and
kale. These members of the cabbage family make an excellent stir fry and can
really liven up a salad. But most importantly, components in these vegetables
may help your body defend against cancers such as colon, breast, lung, and
cervix.
Dark
green leafy vegetables such as mustard greens, lettuce, kale, chicory, spinach,
and chard have an abundance of fiber, folate, and carotenoids. These nutrients may help protect
against cancer of the mouth, larynx, pancreas, lung, skin, and stomach.
Curcumin
is the main ingredient in the Indian spice turmeric and a potential cancer
fighter. Lab studies show it can suppress the transformation, proliferation,
and invasion of cancerous cells for a wide array of cancers.
How
you cook meat can make a difference in how big a cancer risk it poses. Frying,
grilling, and broiling meats at very high temperatures causes chemicals to form
that may increase cancer risk. Other cooking methods such as stewing, braising,
or steaming appear to produce fewer of those chemicals. And when you do stew
the meat, remember to add plenty of healthy, protective vegetables.
Strawberries
and raspberries have a phytochemical
called ellagic
acid. This powerful antioxidant may actually fight cancer in several ways at
once, including deactivating certain cancer causing substances and slowing the
growth of cancer cells.
The
potent antioxidents in
blueberries may have wide value in supporting our health, starting with cancer.
Antioxidants fight cancer by ridding the body of free radicals before they can
do their damage to cells. Try topping oatmeal, cold cereal, yogurt, even salad
with blueberries to boost your intake of these healthful berries.
Sugar
may not cause cancer directly. But it may displace other nutrient-rich foods
that help protect against cancer. And it increases calorie counts, which
contributes to overweight and obesity. Excess weight can be a cancer risk.
Fruit offers a sweet alternative in a vitamin-rich package.
Limit alcohol to slash cancer risk. Cancers
of the mouth, throat, larynx, esophagus, liver, and breast are all linked with
drinking alcohol. Alcohol may also raise the risk for cancer of the colon and
rectum. The American Cancer Society says that even the suggested daily limit of
2 drinks for men and 1 for women elevates the risk. Women at higher risk for
breast cancer may want to talk with a doctor about what amount of alcohol, if
any, is safe based on their personal risk factors.
Wednesday, February 26, 2014
Be aware! Soy supplements with isoflavones may “reprogram” breast cancer cells.
A reason you might want to avoid soy protein isolates and soy supplements.
Women with estrogen-responsive breast cancer who consume soy protein supplements containing isoflavones to alleviate the side effects of menopause may be accelerating progression of their cancer, changing it from a treatable subtype to a more aggressive, less treatable form of the disease, new research suggests.
The study, published in Molecular Nutrition and Food Research, raises troubling questions about the safety and the potential health consequences associated with long-term use of dietary supplements containing soy isoflavones, such as the phytoestrogen genistein.
Scientists at the Univ. of Illinois, Virginia Polytechnic and State Univ. and the National Center for Toxicological Research collaborated on the research. Three preclinical animal studies using mice examined the response of estrogen-dependent breast cancer cells to estradiol and to several levels of genistein delivered in purified forms (500 and 700 ppm) and as soy protein isolate (180 ppm).
The genistein blood levels found in the mice were similar to the serum concentrations found in women whose diets are high in isoflavones.
The soy protein isolate had the natural level of isoflavones found in many commercial protein supplements sold in grocery stores and nutrition shops, said co-author Juan Andrade, who is a prof. of food science and human nutrition at Illinois.
Estradiol and all three genistein concentrations stimulated tumor growth in mice, but when the estradiol implants and higher-dose dietary genistein (750 ppm) were removed, the tumors regressed completely.
Tumors also regressed in the mice that consumed the lower dose (500 ppm) of genistein, but the regression terminated with the tumors at significantly larger sizes than those in the control group.
In the group that consumed soy protein isolate, tumor regression did not occur during the withdrawal phase—instead, the breast cancer cells continued to grow.
“The lower dose of genistein actually does something that is potentially problematic,” said co-author William Helferich, who is a prof. in the same department. “A very low dose of genistein effectively reprograms the tumor cells from estrogen-dependent to estrogen independent, converting them into a tumor that no longer needs estrogen to grow and will not respond to many of the current anti-estrogen therapies.”
After analyzing gene expression markers, the authors speculate that long-term consumption of the lower dose of genistein elicited changes in the breast cancer cells that reprogrammed them from luminal subtype A—the most common and treatable type of breast cancer—to luminal subtype B, a more aggressive and rapidly growing type of tumor that has a poorer prognosis.
The tumors in the mice on the low-dose (500 ppm) genistein diet and the soy protein isolate diet also showed increased expression of the oncoprotein epidermal growth factor receptor 2 (HER2).
HER2 expression, which occurs in 20 to 25% of breast cancer patients, correlates to a poor prognosis because it is associated with endocrine resistance and with higher-grade tumors that proliferate more quickly.
Early epidemiological studies associated whole-soy food consumption with myriad health benefits related to menopause, cardiovascular disease and osteoporosis and with lower rates of breast cancer among Asian populations.
More recent findings from isoflavone supplement studies have been mixed, with some researchers suggesting that supplements containing genistein, including soy protein isolates, may have negative effects on estrogen-receptor positive breast cancer.
In a 2004 study published in Carcinogenesis, Helferich and his
co-authors found that soy flour contained biologically active compounds that appeared to greatly inhibit genistein’s impact on tumor growth.
co-authors found that soy flour contained biologically active compounds that appeared to greatly inhibit genistein’s impact on tumor growth.
“Lifelong consumption of mostly whole-soybean foods such as tofu, tempeh, etc. as is consumed in Asia is probably healthy and protective because Asian populations consume soy as a complex mixture of bioactive compounds and do so throughout their lifetimes,” Helferich said. “However, the way that we consume soy in the West—through highly enriched isoflavones-containing extracts or as dietary supplements, usually later in life—is probably not going to produce the same effects.”
The findings of the current study are particularly troubling because they suggest that dietary quantities of soy foods – rather than the highly enriched isoflavone-containing extracts and pure compounds often found in dietary estrogenic supplements for women—may have serious consequences for certain populations, especially breast cancer patients, Helferich said.
Source: News Bureau Illinois
Subscribe to:
Posts (Atom)